Determination of rosmarinic acid and its N‐substituted analog A1 in rat plasma using high‐performance liquid chromatography–tandem mass spectrometry and its application in pharmacokinetics
Rapid Communications in Mass Spectrometry · 2023
DOI: 10.1002/rcm.9598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rapid Communications in Mass Spectrometry, 2023. Verfasst von Shujie Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical College, Guangxi Medical University, Nanning, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Province, Youth Fund Projects of Guangxi University of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
The aim of this study was to determine the concentration of rosmarinic acid (RA) and its analog (E)‐3‐(3,4‐dihydroxyphenyl)‐2‐(3‐(3,4‐dihydroxyphenyl)acrylamido)propanoic acid (A1) in rat plasma following oral administration. The significance of this study lies in the development of a rapid, sensitive, and alternative method using liquid chromatography‐tandem mass spectrometry for the accurate quantification and identification of RA and A1 in vivo.
Methods
Liquid chromatography‐tandem mass spectrometry was employed to analyze RA and A1 in rat plasma. A C18 column (1.9 µm, 2.1 × 100 mm) with a C18 guard column (5 µm, 2.1 × 10 mm) and a triple‐quadrupole mass spectrometer combined with an electrospray ionization source were utilized. Sample pretreatment involved a one‐step protein precipitation using isopropanol:ethyl acetate (20:80, v/v) as the solvent. Pseudoephedrine hydrochloride served as a standard.
Results
The developed method exhibited a linear relationship within the concentration ranges of 5‐750 ng/ml for both RA and A1. Relative standard deviations in daily courses were less than 15%, and the relative errors recorded were within 15%. This is the first study to concentrate on determining A1 and RA in rat plasma through oral administration.
Conclusions
The liquid chromatography‐tandem mass spectrometry method developed in this study offers a rapid, sensitive, and alternative approach for the accurate quantification and identification of RA and A1 in vivo. The findings serve as a significant foundation for evaluating the clinical applications of the medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pharmaceutical College, Guangxi Medical University, Nanning, China.
- Guangxi University of Chinese Medicine, Nanning, China.
ORCID-Profile: Minjie Jiang
Förderung
- Natural Science Foundation of Guangxi Province
- Youth Fund Projects of Guangxi University of Traditional Chinese Medicine
Zitieren
APA
Fu, S., Zhang, Q., Zhang, S., Jiang, W., & Jiang, M. (2023). Determination of rosmarinic acid and its N‐substituted analog A1 in rat plasma using high‐performance liquid chromatography–tandem mass spectrometry and its application in pharmacokinetics. Rapid Communications in Mass Spectrometry. https://doi.org/10.1002/rcm.9598
Vancouver
Fu S, Zhang Q, Zhang S, Jiang W, Jiang M. Determination of rosmarinic acid and its N‐substituted analog A1 in rat plasma using high‐performance liquid chromatography–tandem mass spectrometry and its application in pharmacokinetics. Rapid Communications in Mass Spectrometry. 2023. doi:10.1002/rcm.9598
BibTeX
@article{Fu2023,
author = {Fu, Shujie and Zhang, Qinglang and Zhang, Shiyu and Jiang, Weizhe and Jiang, Minjie},
title = {Determination of rosmarinic acid and its N‐substituted analog A1 in rat plasma using high‐performance liquid chromatography–tandem mass spectrometry and its application in pharmacokinetics},
journal = {Rapid Communications in Mass Spectrometry},
year = {2023},
doi = {10.1002/rcm.9598}
}
EUVIMED